切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - endothelin receptor - M3 Receptors - 5-HT7 Receptors - Insulin-like growth factors (IGFs)

9 件产品

每页
清除全部
  1. FR 139317
    B5082 FR 139317
    Target: endothelin receptor
    Summary: 选择性ETA内皮素受体拮抗剂
      Soluble to 100 mM in 1eq. HCl and to 100 mM in DMSO
  2. Otilonium Bromide
    B1607 Otilonium Bromide
    中文名: 奥替溴铵
    Target: M3 Receptors
    Summary: AChR抑制剂
      ≥28.18 mg/mL
      ≥55.8 mg/mL
  3. Lurasidone HCl
    B1477 Lurasidone HCl
    中文名: 盐酸鲁拉西酮
    Target: 5-HT2 Receptors|D2 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺D2/5-HT2A/5-HT7/5-HT1A抑制剂
      ≥11.11 mg/mL
      insoluble in H2O
  4. Quetiapine Fumarate
    B1490 Quetiapine Fumarate
     1 Citation
    中文名: 富马酸奎硫平
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺受体拮抗剂
      ≥11.03 mg/mL
      insoluble in H2O
  5. Darifenacin HBr
    B1600 Darifenacin HBr
    中文名: 氢溴酸达非那新
    Target: M3 Receptors
    Summary: 选择性M3毒蕈碱受体拮抗剂
      ≥20.2 mg/mL
      insoluble in H2O
  6. Solifenacin succinate
    B1614 Solifenacin succinate
    中文名: 琥珀酸索非那新
    Target: M3 Receptors
    Summary: 毒蕈碱受体拮抗剂
      ≥24.05 mg/mL
      ≥53.6 mg/mL
  7. AZD-3463
    A8620 AZD-3463
     3 Citation
    Target: ALK|Insulin-like growth factors (IGFs)
    Summary: ALK/IGF1R抑制剂
      ≥11.22 mg/mL
      insoluble in H2O
  8. Atropine sulfate monohydrate
    A8369 Atropine sulfate monohydrate
    中文名: 硫酸阿托品一水合物
    Target: M3 Receptors|M1 Receptors|M2 Receptors|M4 Receptors|M5 Receptors
    Summary: MAChRs拮抗剂
      ≥34.74 mg/mL
      ≥56.5 mg/mL
  9. Vortioxetine
    A3926 Vortioxetine
    中文名: 沃替西汀
    Target: 5-HT1 Receptors|5-HT7 Receptors|5-HT3 Receptors|SERT
    Summary: 5-HT受体拮抗剂
      ≥14.92 mg/mL
      insoluble in H2O

9 件产品

每页